DECIPHERA PHARMACEUTICALS IN

CUSIP: 24344T101 Class: Common Stock

UBS ASSET MANAGEMENT AMERICAS INC's Holding History (CIK: 0000861177)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 398,540 Value ($000) $6,269 Avg Close Range
Q4 2023
Shares 400,044 Value ($000) $6,453 Avg Close Range
Q3 2023
Shares 402,898 Value ($000) $5,125 Avg Close Range
Q2 2023
Shares 416,306 Value ($000) $6,432 Avg Close Range
Q1 2023
Shares 416,306 Value ($000) $6,432 Avg Close Range
Q4 2022
Shares 35,951 Value ($000) $589 Avg Close Range
Q3 2022
Shares 52,637 Value ($000) $973,786 Avg Close Range
Q2 2022
Shares 50,511 Value ($000) $664,220 Avg Close Range
Q1 2022
Shares 44,674 Value ($000) $414,129 Avg Close Range
Q4 2021
Shares 44,674 Value ($000) $436,465 Avg Close Range
Q3 2021
Shares 357,623 Value ($000) $12,152,028 Avg Close Range
Q2 2021
Shares 392,978 Value ($000) $14,386,925 Avg Close Range
Q1 2021
Shares 285,801 Value ($000) $12,815,318 Avg Close Range
Q4 2020
Shares 388,211 Value ($000) $22,155,201 Avg Close Range
Q3 2020
Shares 283,389 Value ($000) $14,537,857 Avg Close Range
Q2 2020
Shares 270,713 Value ($000) $16,166,980 Avg Close Range
Q1 2020
Shares 283,402 Value ($000) $11,667,661 Avg Close Range
Q4 2019
Shares 311,744 Value ($000) $19,402,946 Avg Close Range
Q3 2019
Shares 226,999 Value ($000) $7,704,346 Avg Close Range